Literature DB >> 28680135

Rheumatoid arthritis: JAK-ing up inadequate RA therapy.

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28680135     DOI： 10.1038/nrrheum.2017.114

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.

Authors:  Roy Fleischmann; Eduardo Mysler; Stephen Hall; Alan J Kivitz; Robert J Moots; Zhen Luo; Ryan DeMasi; Koshika Soma; Richard Zhang; Liza Takiya; Svitlana Tatulych; Christopher Mojcik; Sriram Krishnaswami; Sujatha Menon; Josef S Smolen
Journal:  Lancet       Date:  2017-06-16       Impact factor: 79.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.